The combination of a going concern warning, severe revenue decline, minimal cash ($129K), and a highly dilutive equity line at a discount creates a toxic capital structure dynamic. Monitor whether the company can regain NYSE American compliance by Feb 2028 and whether it draws down on the equity line, which would accelerate dilution. The $2.7M in post-period senior unsecured notes provides minimal runway. Watch for any reverse split or restructuring announcements.
Executive Summary
Knorex Ltd. (KNRX) filed an F-1 registration statement to register up to 156,787,119 Class A ordinary shares for resale by selling shareholders under an equity line of credit (Purchase Agreement) that provides up to $50 million in potential gross proceeds. The filing reveals a deeply distressed company: revenue declined 44% YoY to $6.0 million in FY2025, net loss widened to $11.5 million, and the company has a working capital deficit of ~$7.7 million and a shareholders' deficit of ~$6.5 million. The auditors have issued a going concern opinion. The company is also facing potential delisting from NYSE American due to non-compliance with continued listing standards (stockholders' equity deficiency). The equity line itself is highly dilutive — the registered shares represent ~84% of current outstanding shares — and the purchase price is at a 1-3% discount to market, creating persistent downward pressure.
Key Financial Metrics
Key Facts
- Revenue declined 44.2% YoY from $10.8M (FY2024) to $6.0M (FY2025), driven by a ~$5.4M drop in U.S. revenue after the largest customer (40.6% of FY2025 revenue) materially reduced business due to U.S. import tariffs impacting its end-clients.
- Net loss attributable to shareholders widened to $11.5M in FY2025 from $5.9M in FY2024; accumulated deficit reached $62.2M as of Dec 31, 2025.
- Working capital deficit of ~$7.7M and shareholders' deficit of ~$6.5M as of Dec 31, 2025; auditors issued a going concern opinion.
- Company received an NYSE American delisting notice on Aug 21, 2026 for non-compliance with stockholders' equity standards ($2M/$4M thresholds); has until Feb 21, 2028 to regain compliance.
- Equity line of credit (Purchase Agreement) allows sale of up to $50M of Class A shares at a 1-3% discount to market; 156.8M shares registered for resale, representing ~84% of current outstanding shares (30.4M).
- Cash and cash equivalents fell to just $129,104 as of Dec 31, 2025, from $824,728 a year earlier; operating cash outflow was $10.4M in FY2025.
- Customer count dropped from 37 to 26 YoY; average revenue per customer fell 20.5% to $232,252.
- Top 5 customers accounted for 74% of FY2025 revenue; customer concentration remains high.
- Company has a dual-class structure: Class B shares (15.7% of shares) hold 49.6% of voting power, concentrated with founder/CEO Dr. Khar Heng Choo.
Financial Impact
Revenue decline of $4.8M (44.2% YoY); net loss increase of $5.7M to $11.5M; working capital deficit of $7.7M; shareholders' deficit of $6.5M; potential dilution of up to 84% from the equity line.
Risk Factors
- Going concern risk: auditors expressed substantial doubt; cash of $129K is insufficient to fund operations.
- NYSE American delisting risk: stockholders' equity deficiency of $6.5M vs. $2M/$4M thresholds; cure period through Feb 2028.
- Extreme dilution risk: the equity line allows up to 156.8M new shares (84% of current float) at a discount, creating persistent selling pressure.
- Customer concentration: top customer (40.6% of revenue) reduced business due to tariff impacts; no assurance of replacement.
- Dual-class structure concentrates 49.6% voting power with founder/CEO, limiting minority shareholder influence.
- High leverage: total liabilities of $13.4M vs. total assets of $7.0M; $2.3M in convertible notes and $4.2M in short-term third-party loans.
- Foreign private issuer status limits U.S. shareholder protections; Cayman Islands incorporation complicates enforcement of judgments.
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| F-1 Filing (Primary) | 0001493152-26-043539 |
| Exhibit: ex5-1.htm | 0001493152-26-043539 |
| Exhibit: ex107.htm | 0001493152-26-043539 |
| Exhibit: ex23-1.htm | 0001493152-26-043539 |
| Exhibit: ex23-2.htm | 0001493152-26-043539 |
| Document: 0001493152-26-043539-index-headers.html | 0001493152-26-043539 |
| Document: 0001493152-26-043539-index.html | 0001493152-26-043539 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $0.1881 $0.1850 | ▲ +1.65% | ▲ +1.59% | $0.1700 (+9.62%) |
Sep 28, 2026 28d ago | 6-K | $1.23 $0.3700 | ▼ −69.92% | ▼ −69.73% | $0.1700 (−86.18%) |
Sep 28, 2026 29d ago | EFFECT | $1.23 $0.3700 | ▼ −69.92% | ▼ −69.73% | $0.1700 (−86.18%) |
Sep 21, 2026 5w ago | F-1 | $0.3030 $0.3020 | ▲ +0.33% | ▲ +0.31% | $0.1700 (+43.89%) |
Aug 26, 2026 8w ago | 6-K | $0.4199 $0.4099 | ▲ +2.38% | ▲ +2.15% | $0.1700 (+59.51%) |
Jun 26, 2026 17w ago | 6-K | $0.4740 $0.4830 | ▲ +1.90% | ▲ +1.12% | $0.1700 (−64.14%) |
Jun 11, 2026 19w ago | 6-K | $0.4500 $0.4261 | ▼ −5.31% | ▼ −7.07% | $0.1700 (−62.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers